SIGNUS USA successfully completed the first surgery in the U.S. utilizing the VertaConnect spinal implant system, marking the official clinical debut of this new SIGNUS technology in the United States.
The VertaConnect system is a next-generation transforaminal lumbar interbody fusion (TLIF) implant engineered to maximize performance in both traditional open procedures and with endoscopic approaches. Its expandable design, large contact surface, and open architecture empower surgeons to achieve superior stability, enhanced osseointegration, and optimal spinal alignment through a streamlined, efficient surgical approach.
SIGNUS USA is the newly established US subsidiary of SIGNUS Medizintechnik, a Germany-based, family-owned company with more than 30 years of experience in spinal implant design, manufacturing, and innovation.
“At SIGNUS, we don’t just develop implants…we build partnerships,” said Mareike Siedler, Chief Executive Officer of SIGNUS USA. “Our mission is to equip surgeons with advanced, dependable solutions that improve patients’ lives and enhance confidence in the operating room. Bringing SIGNUS to the United States is about sharing decades of knowledge, innovation, and trust.”
SIGNUS USA successfully completed the first surgery in the U.S. utilizing the VertaConnect spinal implant system, marking the official clinical debut of this new SIGNUS technology in the United States.
The VertaConnect system is a next-generation transforaminal lumbar interbody fusion (TLIF) implant engineered to maximize performance in both...
SIGNUS USA successfully completed the first surgery in the U.S. utilizing the VertaConnect spinal implant system, marking the official clinical debut of this new SIGNUS technology in the United States.
The VertaConnect system is a next-generation transforaminal lumbar interbody fusion (TLIF) implant engineered to maximize performance in both traditional open procedures and with endoscopic approaches. Its expandable design, large contact surface, and open architecture empower surgeons to achieve superior stability, enhanced osseointegration, and optimal spinal alignment through a streamlined, efficient surgical approach.
SIGNUS USA is the newly established US subsidiary of SIGNUS Medizintechnik, a Germany-based, family-owned company with more than 30 years of experience in spinal implant design, manufacturing, and innovation.
“At SIGNUS, we don’t just develop implants…we build partnerships,” said Mareike Siedler, Chief Executive Officer of SIGNUS USA. “Our mission is to equip surgeons with advanced, dependable solutions that improve patients’ lives and enhance confidence in the operating room. Bringing SIGNUS to the United States is about sharing decades of knowledge, innovation, and trust.”
Copy to clipboard 
